NCT01514578View on ClinicalTrials.gov

Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy
Interventions
DRUG

TRV130A

Intravenous infusion of 1 hour duration

DRUG

Dextrose in Water

Intravenous infusion of 1 hour duration

Trial Locations (1)

68154

ICON Development Solutions, Omaha

All Listed Sponsors
lead

Trevena Inc.

INDUSTRY

NCT01514578 - Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males | Biotech Hunter | Biotech Hunter